Clinical trial
Efficacy and Safety of Two Fixed-combination Antihypertensive Regimens, Amtrel® and Co-Diovan® in Type 2 Diabetes Hypertension Patients With Microalbuminuria
NCT01375322 is registered in ClinicalTrials.gov with TSH Biopharm Corporation Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Two Fixed-combination Antihypertensive Regimens, Amtrel® and Co-Diovan® in Type 2 Diabetes Hypertension Patients With Microalbuminuria
- Lead sponsor
- TSH Biopharm Corporation Limited
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- June 30, 2010
- Enrollment
- 226 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.